NCT04793295

Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects

A Phase I, Open-Label, Four-Part, Single-Sequence Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 112 (actual)
• Sponsor: Tanabe Pharma America, Inc. · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

Study is to investigate drug levels in the blood after taking single or multiple doses of the study drug, MT-7117, in healthy adults when taken together with another drug. This study will also look at the safety and the body's ability to tolerate MT-7117

Conditions

• Healthy Subjects

Interventions

Type	Name	Description
DRUG	MT-7117	MT-7117

Timeline

• Start date: 2021-03-23
• Primary completion: 2022-02-04
• Completion: 2022-02-04
• First posted: 2021-03-11
• Last updated: 2023-05-15

Locations

2 sites across 1 country: United States

Regulatory

• FDA-regulated drug study